ArticleJournal of clinical and experimental hepatology

Ephrin-A4 Ligand (EFNA4) Predicts Poor Prognosis of Hepatocellular Carcinoma and Promotes Tumor Proliferation.

Peng Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.